NCT00035386View on ClinicalTrials.gov

Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study

PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 30, 2002

Study Completion Date

April 30, 2003

Conditions
Hypertrophic Cardiomyopathy
Interventions
PROCEDURE

trans-right ventricular alcohol septal ablation (TRVASA)

Trial Locations (1)

20892

National Heart, Lung and Blood Institute (NHLBI), Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00035386 - Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study | Biotech Hunter | Biotech Hunter